勘误:Balchaturbhadra Churna 作为治疗儿科 SARS-CoV2 感染的潜在药物的硅学研究。

Ayu Pub Date : 2023-01-01 Epub Date: 2024-02-21 DOI:10.4103/ayu.ayu_74_24
{"title":"勘误:Balchaturbhadra Churna 作为治疗儿科 SARS-CoV2 感染的潜在药物的硅学研究。","authors":"","doi":"10.4103/ayu.ayu_74_24","DOIUrl":null,"url":null,"abstract":"<p><p>[This corrects the article on p. 146 in vol. 43.].</p>","PeriodicalId":502094,"journal":{"name":"Ayu","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10946665/pdf/","citationCount":"0","resultStr":"{\"title\":\"Erratum: Balchaturbhadra Churna as a potential medicine for SARS-CoV2 infection in pediatric setting an in silico study.\",\"authors\":\"\",\"doi\":\"10.4103/ayu.ayu_74_24\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>[This corrects the article on p. 146 in vol. 43.].</p>\",\"PeriodicalId\":502094,\"journal\":{\"name\":\"Ayu\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10946665/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Ayu\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.4103/ayu.ayu_74_24\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2024/2/21 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Ayu","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4103/ayu.ayu_74_24","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/2/21 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

[这是对第 43 卷第 146 页文章的更正]。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Erratum: Balchaturbhadra Churna as a potential medicine for SARS-CoV2 infection in pediatric setting an in silico study.

[This corrects the article on p. 146 in vol. 43.].

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Ayu
Ayu
自引率
0.00%
发文量
0
期刊最新文献
Safety and efficacy of COROPROTECT kit as an add-on therapy in the management of mild-to-moderate COVID-19: A randomized, placebo-controlled trial. Use of checkerboard assay to determine the synergy between essential oils extracted from leaves of Aegle marmelos (L.) Correa and nystatin against Candida albicans. Comparative Pharmacognostic study of market samples of Tagara collected from five different markets of Kerala with the official source plant Valeriana jatamansi Jones ex Roxb. Erratum: Balchaturbhadra Churna as a potential medicine for SARS-CoV2 infection in pediatric setting an in silico study. Evaluation of the anti-arthritic activity of Rhuflex-F - A proprietary Ayurvedic herbomineral formulation in albino rats.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1